Discovery and Characterization of the Potent and Selective P2X4 InhibitorN-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide (BAY-1797) and Structure-Guided Amelioration of Its CYP3A4 Induction Profile.
Werner, S., Mesch, S., Hillig, R.C., Ter Laak, A., Klint, J., Neagoe, I., Laux-Biehlmann, A., Dahllof, H., Brauer, N., Puetter, V., Nubbemeyer, R., Schulz, S., Bairlein, M., Zollner, T.M., Steinmeyer, A.(2019) J Med Chem 62: 11194-11217
- PubMed: 31746599 
- DOI: 10.1021/acs.jmedchem.9b01304
- Primary Citation of Related Structures:  
6HTY - PubMed Abstract: 
The P2X4 receptor is a ligand-gated ion channel that is expressed on a variety of cell types, especially those involved in inflammatory and immune processes. High-throughput screening led to a new class of P2X4 inhibitors with substantial CYP 3A4 induction in human hepatocytes ...